Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Belgium

Belgium Articles
:
UCB's Cimzia Approved ByThe US FDA

Industry

Belgium drugmaker UCB has received FDA approval to market Cimzia (certolizumab pegol), the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of severe to moderate... 2009-05-15

1 to 1 of 1 results
<< | < | 1 | > | >>


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2012 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS